K
KAILERA THERAPEUTICS, INC. COMMON STOCK
NASDAQ: KLRA (Kailera Therapeutics, Inc.)
最近更新时间: 1小时之前11.99
-0.84 (-6.55%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Kailera Therapeutics, Inc. | - | - |
AIStockmoo 评分
0.0
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.00 |
|
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Bain Capital Investors Llc | 30 Jun 2026 | 26,255,581 |
| Bain Capital Life Sciences Investors, Llc | 30 Jun 2026 | 22,583,268 |
| Canada Pension Plan Investment Board | 30 Jun 2026 | 7,304,688 |
| Atlas Venture Life Science Advisors, Llc | 30 Jun 2026 | 5,171,282 |
| Price T Rowe Associates Inc /Md/ | 30 Jun 2026 | 3,534,410 |
| Adage Capital Partners Gp, L.L.C. | 30 Jun 2026 | 3,208,286 |
| Siren, L.L.C. | 30 Jun 2026 | 2,214,286 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合